{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_0", "document_index": 37, "latency_s": 28.0268739000021, "prompt_toks": 15379, "completion_toks": 94}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Mitragynine\n\nPubChem CID\n\n3034396\n\nStructure\n\nMitragynine_small.png\n\nMitragynine_3D_Structure.png\n\nChemical Safety\n\nIrritant\n\nLaboratory Chemical Safety Summary (LCSS) Datasheet\n\nMolecular Formula\n\nC23H30N2O4\n\nSynonyms\n\nMITRAGYNINE\n\n4098-40-2\n\n(-)-Mitragynine\n\nSkf 12711\n\nMitragynin\n\nMolecular Weight\n\n398.5 g/mol\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nDates\n\nCreate:\n\n2005-06-24\n\nModify:\n\n2025-04-19\n\nDescription\n\nMitragynine is a monoterpenoid indole alkaloid.\n\nMitragynine has been reported in Mitragyna speciosa with data available.\n\nContents\n\n1 Structures\n\n1.1 2D Structure\n\nChemical Structure Depiction\n\nMitragynine.png\n\n1.2 3D Conformer\n\n1.3 Crystal Structures\n\nCOD records with this CID as component\n\n2221951\n\n2 Names and Identifiers\n\n2.1 Computed Descriptors\n\n2.1.1 IUPAC Name\n\nmethyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate\n\nComputed by Lexichem TK 2.7.0 (PubChem release 2021.10.14)\n\n\n                    Context: \n                    This section provides the primary summary information for mitragynine, including its PubChem CID, basic molecular data, key synonyms, chemical structure images, and initial classification as a monoterpenoid indole alkaloid found in Mitragyna speciosa. It serves as the prominent overview box at the top of the full compound record, introducing the core identity, safety, and chemical identifiers before more detailed sections on properties, spectra, uses, toxicity, and related data.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_1", "document_index": 37, "latency_s": 30.505044299992733, "prompt_toks": 15554, "completion_toks": 100}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate\n\nComputed by Lexichem TK 2.7.0 (PubChem release 2021.10.14)\n\n2.1.2 InChI\n\nInChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3/b17-13+/t14-,16+,19+/m1/s1\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.3 InChIKey\n\nLELBFTMXCIIKKX-QVRQZEMUSA-N\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.4 SMILES\n\nCC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC\n\nComputed by OEChem 2.3.0 (PubChem release 2024.12.12)\n\n2.2 Molecular Formula\n\nC23H30N2O4\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\n2.3 Other Identifiers\n\n2.3.1 CAS\n\n4098-40-2\n\n6202-22-8\n\n2.3.2 Deprecated CAS\n\n1383-32-0, 6202-22-8\n\n2.3.3 European Community (EC) Number\n\n863-118-9\n\n2.3.4 UNII\n\nEP479K822J\n\n2.3.5 ChEBI ID\n\nCHEBI:6956\n\n2.3.6 ChEMBL ID\n\nCHEMBL299031\n\n\n                    Context: \n                    This chunk provides the core computed chemical identifiers for mitragynine, including its IUPAC name, InChI, InChIKey, SMILES, molecular formula, CAS numbers, and various database IDs (EC, UNII, ChEBI, ChEMBL). It appears within the \"Names and Identifiers\" section of the compound's PubChem entry, following the summary description and structural depictions, and is essential for unambiguous substance identification and database cross-referencing.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_2", "document_index": 37, "latency_s": 32.589154099987354, "prompt_toks": 15469, "completion_toks": 68}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    4098-40-2\n\n6202-22-8\n\n2.3.2 Deprecated CAS\n\n1383-32-0, 6202-22-8\n\n2.3.3 European Community (EC) Number\n\n863-118-9\n\n2.3.4 UNII\n\nEP479K822J\n\n2.3.5 ChEBI ID\n\nCHEBI:6956\n\n2.3.6 ChEMBL ID\n\nCHEMBL299031\n\n2.3.7 DSSTox Substance ID\n\nDTXSID701032140\n\n2.3.8 HMDB ID\n\nHMDB0041933\n\n2.3.9 KEGG ID\n\nC09226\n\n2.3.10 Metabolomics Workbench ID\n\n49638\n\n2.3.11 Nikkaji Number\n\nJ8.681I\n\n2.3.12 Wikidata\n\nQ414299\n\n2.3.13 Wikipedia\n\nMitragynine\n\n2.4 Synonyms\n\n2.4.1 MeSH Entry Terms\n\n16,17-didehydro-9,17-dimethoxy-17,18-seco-20-alpha-yohimban-16-carboxylic acid methyl ester\n\nkratom alkaloids\n\nmitragynine\n\nmitragynine ethanedisulfonate\n\nmitragynine monohydrochloride\n\nmitragynine, (16E)-isomer\n\nmitragynine, (3beta,16E)-isomer\n\nmitragynine, (3beta,16E,20beta)-isomer\n\nSK and F 12711\n\nSK and F-12711\n\nSKF 12711\n\n2.4.2 Depositor-Supplied Synonyms\n\nMITRAGYNINE\n\n4098-40-2\n\n(-)-Mitragynine\n\nSkf 12711\n\nMitragynin\n\n9-Methoxycorynantheidine\n\nMitragynine [MI]\n\nSK&F 12711\n\nUNII-EP479K822J\n\nCHEBI:6956\n\nHSDB 7901\n\nEP479K822J\n\n\n                    Context: \n                    This chunk appears within the \"Names and Identifiers\" section of the Mitragynine compound page, listing various standardized chemical identifiers—including CAS numbers, EC numbers, database IDs, and synonyms—from multiple chemical and biomedical registries. This section provides essential cross-references for Mitragynine across scientific, regulatory, and pharmacological resources.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_3", "document_index": 37, "latency_s": 29.363246599998092, "prompt_toks": 15508, "completion_toks": 48}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MITRAGYNINE\n\n4098-40-2\n\n(-)-Mitragynine\n\nSkf 12711\n\nMitragynin\n\n9-Methoxycorynantheidine\n\nMitragynine [MI]\n\nSK&F 12711\n\nUNII-EP479K822J\n\nCHEBI:6956\n\nHSDB 7901\n\nEP479K822J\n\nMITRAGYNINE PICRATE\n\nMITRAGYNINE [WHO-DD]\n\nCHEMBL299031\n\n(E)-Methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate\n\nmethyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate\n\n16,17-Didehydro-9,17-dimethoxy-17,18-seco-20-alpha-yohimban-16-carboxylic acid methyl ester\n\nkratom alkaloids\n\nMitragynine (100?g/mL in Methanol)\n\n(.ALPHA.E,2S,3S,12.BETA.S)-3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-.ALPHA.-(METHOXYMETHYLENE)-INDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID METHYL ESTER\n\nINDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID, 3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-.ALPHA.-(METHOXYMETHYLENE)-, METHYL ESTER, (.ALPHA.E,2S,3S,12BS)-\n\n\n                    Context: \n                    This chunk lists synonyms and alternative names for mitragynine, including registry numbers, chemical identifiers, and various nomenclature variants, as found in the broader section detailing chemical names and identifiers within the mitragynine compound information page.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_4", "document_index": 37, "latency_s": 30.671404500026256, "prompt_toks": 15556, "completion_toks": 69}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    INDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID, 3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-.ALPHA.-(METHOXYMETHYLENE)-, METHYL ESTER, (.ALPHA.E,2S,3S,12BS)-\n\nmethyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-4-yl]-3-methoxyprop-2-enoate\n\nMethyl (2E)-2-((2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo(8.7.0.0,.0,)heptadeca-1(10),11(16),12,14-tetraen-4-yl)-3-methoxyprop-2-enoic acid\n\nmethyl (2E)-2-((2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo(8.7.0.0^(2,7).0^(11,16))heptadeca-1(10),11,13,15-tetraen-4-yl)-3-methoxyprop-2-enoate\n\nMethyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.0,.0,]heptadeca-1(10),11(16),12,14-tetraen-4-yl]-3-methoxyprop-2-enoic acid\n\nmethyl (E)-2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyprop-2-enoate\n\nSK&F-12711\n\nMitragynine - 95%\n\nMitragynine - 97%\n\n\n                    Context: \n                    This chunk appears in the \"Synonyms\" section of the Mitragynine compound page, listing various alternative chemical names, systematic names, brand or lab names, and purity-related labels that are used for mitragynine in scientific literature and chemical databases. These synonyms aid in comprehensive search and identification of mitragynine across different resources.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_5", "document_index": 37, "latency_s": 30.878131800011033, "prompt_toks": 15487, "completion_toks": 76}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    methyl (E)-2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyprop-2-enoate\n\nSK&F-12711\n\nMitragynine - 95%\n\nMitragynine - 97%\n\n(E)-methyl 2-((2S,3S,12bR)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-\\ octahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate ethanol solvate\n\n(E)-methyl 2-[(2S,3S,12bR)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-\\ octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyacrylate ethanol solvate\n\nSCHEMBL875799\n\nSCHEMBL875800\n\nSK And F 12711\n\nSK And F-12711\n\nGTPL13149\n\nMitragynine, 1mg/ml in Methanol\n\nLELBFTMXCIIKKX-QVRQZEMUSA-N\n\nDTXSID701032140\n\nGLXC-02988\n\nMitragynine, 0.1mg/ml in Methanol\n\nMSK40382\n\nBDBM50474152\n\nFM26024\n\nMitragynine 100 microg/mL in Methanol\n\nNCGC00488797-01\n\n1ST40382\n\nBM164595\n\nDB-299985\n\nC09226\n\nQ414299\n\n(a-E,2S,3S,12bS)-3-Ethyl-1,2,3,4,6,7,12 ,12b-octahydro-8-methoxy-a-(methoxymethylene)-indolo[2 ,3-a]quinolizine-2-acetic acid methyl ester\n\n\n                    Context: \n                    This chunk is part of the \"Synonyms\" and \"Depositor-Supplied Synonyms\" section, listing alternative chemical names, identifiers, preparation concentrations, and registry numbers used for mitragynine across various chemical, pharmacological, and regulatory databases. These synonyms facilitate cross-referencing mitragynine in scientific literature, chemical inventories, and product formulations.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_6", "document_index": 37, "latency_s": 30.541628800012404, "prompt_toks": 15484, "completion_toks": 52}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    1ST40382\n\nBM164595\n\nDB-299985\n\nC09226\n\nQ414299\n\n(a-E,2S,3S,12bS)-3-Ethyl-1,2,3,4,6,7,12 ,12b-octahydro-8-methoxy-a-(methoxymethylene)-indolo[2 ,3-a]quinolizine-2-acetic acid methyl ester\n\n(alphaE,2S,3S,12betaS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-methoxy-alpha-(methoxymethylene)-indolo(2,3-a)quinolizine-2-acetic acid methyl ester\n\n(E)-methyl2-((2s,3s,12bs)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate\n\nINDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID, 3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-ALPHA-(METHOXYMETHYLENE)-, METHYL ESTER, (ALPHAE,2S,3S,12BS)-\n\nmethyl(e)-2-[(2s,3s,12bs)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate\n\n3 Chemical and Physical Properties\n\n3.1 Computed Properties\n\nProperty Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n398.5 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nXLogP3-AA\n\n\n                    Context: \n                    This chunk lists several depositor-supplied synonyms and identifiers for mitragynine, followed by the beginning of the \"Chemical and Physical Properties\" section, specifically transitioning from alternate names to the computed molecular weight and other physicochemical data for the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_7", "document_index": 37, "latency_s": 30.844953599997098, "prompt_toks": 15326, "completion_toks": 62}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Property Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n398.5 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nXLogP3-AA\n\nProperty Value\n\n3.4\n\nReference\n\nComputed by XLogP3 3.0 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Donor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Acceptor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nRotatable Bond Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nExact Mass\n\nProperty Value\n\n398.22055744 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nMonoisotopic Mass\n\nProperty Value\n\n398.22055744 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n63.8 Å²\n\nReference\n\n\n                    Context: \n                    This chunk lists computed chemical properties of mitragynine, including molecular weight, partition coefficient (XLogP3-AA), exact and monoisotopic mass, and topological polar surface area, as part of the broader chemical and physical property section detailing key structural and physicochemical characteristics of the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_8", "document_index": 37, "latency_s": 30.56723879999481, "prompt_toks": 15275, "completion_toks": 64}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Monoisotopic Mass\n\nProperty Value\n\n398.22055744 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n63.8 Å²\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHeavy Atom Count\n\nProperty Value\n\n29\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nFormal Charge\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nComplexity\n\nProperty Value\n\n624\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nIsotope Atom Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\n\n                    Context: \n                    This chunk lists computed chemical properties of mitragynine—including monoisotopic mass, topological polar surface area, heavy atom count, formal charge, complexity, and stereocenter counts—found in the broader section on chemical and physical properties, following basic identifiers and preceding toxicity, spectral, and pharmacological information.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_9", "document_index": 37, "latency_s": 30.611336400004802, "prompt_toks": 15314, "completion_toks": 79}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Computed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCovalently-Bonded Unit Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCompound Is Canonicalized\n\nProperty Value\n\nYes\n\nReference\n\nComputed by PubChem (release 2021.10.14)\n\n3.2 Experimental Properties\n\n3.2.1 Color / Form\n\nWhite amorphous powder\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n3.2.2 Boiling Point\n\n235 °C at 5 mm Hg\n\nLide, D.R. CRC Handbook of Chemistry and Physics 88TH Edition 2007-2008. CRC Press, Taylor & Francis, Boca Raton, FL 2007, p. 3-380\n\n3.2.3 Melting Point\n\n104 °C\n\nLide, D.R. CRC Handbook of Chemistry and Physics 88TH Edition 2007-2008. CRC Press, Taylor & Francis, Boca Raton, FL 2007, p. 3-380\n\n\n                    Context: \n                    This chunk appears in the \"Chemical and Physical Properties\" section of the Mitragynine PubChem page, immediately transitioning from computed molecular descriptor data—such as stereochemistry and canonicalization—to experimentally measured physical properties like color, form, boiling point, and melting point. This section provides key reference data on the physical characteristics of mitragynine, useful for identification and laboratory work.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_10", "document_index": 37, "latency_s": 30.338905400014482, "prompt_toks": 15356, "completion_toks": 78}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    3.2.3 Melting Point\n\n104 °C\n\nLide, D.R. CRC Handbook of Chemistry and Physics 88TH Edition 2007-2008. CRC Press, Taylor & Francis, Boca Raton, FL 2007, p. 3-380\n\n3.2.4 Solubility\n\nSoluble in alcohol, chloroform, acetic acid\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n3.2.5 Optical Rotation\n\nSpecific optical rotation: +39 deg at 25 °C/D (chloroform)\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n4 Spectral Information\n\n4.1 Mass Spectrometry\n\n4.1.1 GC-MS\n\nTechnique\n\nGC/MS\n\nSource of Spectrum\n\nH.H.Maurer, M.Meyer, K.Pfleger, A.A. Weber / University of Saarland, D-66424 Homburg Germany\n\nCopyright\n\nCopyright © 2023-2025 Wiley-VCH GmbH. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.1.2 MS-MS\n\n1 of 6\n\nView All\n\nSpectra ID\n\n2235783\n\nIonization Mode\n\nPositive\n\nSPLASH\n\n\n                    Context: \n                    This chunk appears in the \"Chemical and Physical Properties\" section of the document on mitragynine, specifically as part of the \"Experimental Properties\" subsection. It provides key laboratory data on melting point, solubility, and optical rotation. Immediately following these experimental properties, the document transitions to the \"Spectral Information\" section, beginning with mass spectrometry data and sources.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_11", "document_index": 37, "latency_s": 31.51123799997731, "prompt_toks": 15403, "completion_toks": 101}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Copyright\n\nCopyright © 2023-2025 Wiley-VCH GmbH. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.1.2 MS-MS\n\n1 of 6\n\nView All\n\nSpectra ID\n\n2235783\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-00fr-0951000000-4ce6e7d171b4a8b9f426\n\nTop 5 Peaks\n\n174.09241 100\n\n226.14505 37.80\n\n238.14587 34.50\n\n399.22882 18.40\n\n110.09757 17.20\n\nThumbnail\n\nThumbnail\n\n2 of 6\n\nView All\n\nSpectra ID\n\n2236066\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0abc-0900000000-0e9bd1a4bf69873c1855\n\nTop 5 Peaks\n\n159.06828 100\n\n174.09233 57.46\n\n144.08147 29.03\n\n143.07457 22.42\n\n117.07032 19.82\n\nThumbnail\n\nThumbnail\n\n4.1.3 LC-MS\n\n1 of 15\n\nView All\n\nAccession ID\n\nMSBNK-RIKEN-PR301315\n\nAuthors\n\nTetsuya Mori, Center for Sustainable Resource Science, RIKEN\n\nInstrument\n\nLC, Waters Acquity UPLC System; MS, Waters Xevo G2 Q-Tof\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n6V\n\nColumn Name\n\nAcquity bridged ethyl hybrid C18 (1.7 um, 2.1 mm * 100 mm, Waters)\n\n\n                    Context: \n                    This chunk appears in the \"4 Spectral Information\" section of the Mitragynine compound page, specifically under \"4.1 Mass Spectrometry.\" It provides detailed MS-MS (tandem mass spectrometry) data, including spectra IDs, ionization mode, SPLASH identifiers, and top peak values, followed by LC-MS spectra details, such as instrument information, authors, and experimental parameters. This information supports the compound's identification and analytical characterization within the full database entry.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_12", "document_index": 37, "latency_s": 30.424139299982926, "prompt_toks": 15364, "completion_toks": 79}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Instrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n6V\n\nColumn Name\n\nAcquity bridged ethyl hybrid C18 (1.7 um, 2.1 mm * 100 mm, Waters)\n\nRetention Time\n\n5.539417\n\nPrecursor m/z\n\n399.2278339\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n399.22916 999\n\n174.09209 175\n\n226.145 84\n\n238.14507 73\n\n110.09666 31\n\nSPLASH\n\nsplash10-0002-0219000000-624a92b29517193f1f20\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\nReference\n\nTsugawa H., Nakabayashi R., Mori T., Yamada Y., Takahashi M., Rai A., Sugiyama R., Yamamoto H., Nakaya T., Yamazaki M., Kooke R., Bac-Molenaar JA., Oztolan-Erol N., Keurentjes JJB., Arita M., Saito K. (2019) \"A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms\" Nature Methods 16(4):295-298. [doi:10.1038/s41592-019-0358-2]\n\n2 of 15\n\nView All\n\nAccession ID\n\nMSBNK-RIKEN-PR301319\n\nAuthors\n\nTetsuya Mori, Center for Sustainable Resource Science, RIKEN\n\nInstrument\n\n\n                    Context: \n                    This chunk is from the \"Spectral Information\" section, specifically under \"4.1 Mass Spectrometry\" and \"4.1.3 LC-MS\" for mitragynine. It details LC-ESI-QTOF MS2 experimental conditions and key mass spectral peaks for compound identification, including instrument parameters, precursor ion information, detected fragment peaks, and bibliographic reference.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_13", "document_index": 37, "latency_s": 31.648850999976275, "prompt_toks": 15378, "completion_toks": 118}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    2 of 15\n\nView All\n\nAccession ID\n\nMSBNK-RIKEN-PR301319\n\nAuthors\n\nTetsuya Mori, Center for Sustainable Resource Science, RIKEN\n\nInstrument\n\nLC, Waters Acquity UPLC System; MS, Waters Xevo G2 Q-Tof\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n6V\n\nColumn Name\n\nAcquity bridged ethyl hybrid C18 (1.7 um, 2.1 mm * 100 mm, Waters)\n\nRetention Time\n\n5.539417\n\nPrecursor m/z\n\n399.2278339\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n399.2283 999\n\n399.28589 31\n\nSPLASH\n\nsplash10-0002-0009000000-26a47ceebb3a2a3a9959\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\nReference\n\nTsugawa H., Nakabayashi R., Mori T., Yamada Y., Takahashi M., Rai A., Sugiyama R., Yamamoto H., Nakaya T., Yamazaki M., Kooke R., Bac-Molenaar JA., Oztolan-Erol N., Keurentjes JJB., Arita M., Saito K. (2019) \"A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms\" Nature Methods 16(4):295-298. [doi:10.1038/s41592-019-0358-2]\n\n4.1.4 Other MS\n\n\n                    Context: \n                    This chunk is part of the \"Spectral Information\" section, specifically detailing one of several LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) spectra for mitragynine. It provides experimental parameters (such as instrument type, ionization mode, retention time, precursor m/z, and top peak intensities) and references for identifying and analyzing mitragynine. This information supports analytical identification, metabolomics studies, and chemical characterization within the broader chemical, physical, and pharmacological profile of mitragynine presented on the page.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_14", "document_index": 37, "latency_s": 33.69188990001567, "prompt_toks": 15397, "completion_toks": 131}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    4.1.4 Other MS\n\n1 of 2\n\nMoNA ID\n\nCCMSLIB00005720315\n\nMS Category\n\nExperimental\n\nMS Type\n\nOther\n\nMS Level\n\nMS2\n\nPrecursor Type\n\n[M+H]+\n\nPrecursor m/z\n\n399.24\n\nInstrument\n\nOrbitrap\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n399.240784 100\n\n174.097046 49.39\n\n400.243805 26.89\n\n226.151154 17.38\n\n238.151474 15.08\n\nSPLASH\n\nsplash10-0002-0749200000-5da795ba9c57970f05fe\n\nThumbnail\n\nThumbnail\n\n2 of 2\n\nMoNA ID\n\nCCMSLIB00005720316\n\nMS Category\n\nExperimental\n\nMS Type\n\nOther\n\nMS Level\n\nMS2\n\nPrecursor Type\n\n[M+H]+\n\nPrecursor m/z\n\n399.24\n\nInstrument\n\nOrbitrap\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n399.240784 100\n\n174.097046 49.39\n\n400.243805 26.89\n\n226.151154 17.38\n\n238.151474 15.08\n\nSPLASH\n\nsplash10-0002-0749200000-5da795ba9c57970f05fe\n\nThumbnail\n\nThumbnail\n\n4.2 UV Spectra\n\nUV max: 226, 292 nm (epsilon 41, 150, 660)\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n4.3 IR Spectra\n\n\n                    Context: \n                    This chunk appears in the \"Spectral Information\" section, specifically under mass spectrometry data (\"Other MS\") for mitragynine. It presents experimental MS/MS spectra (MS2, positive mode, Orbitrap instrument) from the MoNA database, listing MoNA IDs, precursor details, prominent peaks, and SPECTRAL hashes (SPLASH) for mitragynine. Preceding this are GC-MS and MS-MS results; following it are UV, IR, and Raman spectroscopy data, all of which support compound identification and analytical characterization within the broader chemical and physical data provided for mitragynine.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_15", "document_index": 37, "latency_s": 27.08198300001095, "prompt_toks": 15319, "completion_toks": 81}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n4.3 IR Spectra\n\n4.3.1 FTIR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nKBr0\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nCayman Chemical Company\n\nCatalog Number\n\n<a href=https://www.caymanchem.com/product/11151>11151</a>\n\nLot Number\n\n0467235-2\n\nCopyright\n\nCopyright © 2012-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.3.2 ATR-IR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nATR-Neat (DuraSamplIR II)\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nCayman Chemical Company\n\nCatalog Number\n\n<a href=https://www.caymanchem.com/product/11151>11151</a>\n\nLot Number\n\n0467235-2\n\nCopyright\n\nCopyright © 2014-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.4 Raman Spectra\n\nTechnique\n\nFT-Raman\n\nSource of Spectrum\n\nForensic Spectral Research\n\n\n                    Context: \n                    This section provides detailed spectral information for mitragynine, specifically IR (infrared) spectra, including FTIR and ATR-IR data, describing instrumentation, techniques, and sample sources. It is part of the broader \"Spectral Information\" section, which also includes mass spectrometry, UV, and Raman spectra, supporting the compound’s identification and characterization within the PubChem compound record.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_16", "document_index": 37, "latency_s": 29.997325200005434, "prompt_toks": 15265, "completion_toks": 68}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    0467235-2\n\nCopyright\n\nCopyright © 2014-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.4 Raman Spectra\n\nTechnique\n\nFT-Raman\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nCayman Chemical Company\n\nCatalog Number\n\n<a href=https://www.caymanchem.com/product/11151>11151</a>\n\nLot Number\n\n0467235-2\n\nCopyright\n\nCopyright © 2015-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n5 Related Records\n\n5.1 Related Compounds with Annotation\n\nFollow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see here for details), but these live search links provide equivalent functionality to the table that was previously shown here.\n\n5.2 Related Compounds\n\nSame Connectivity Count\n\n37\n\nSame Stereo Count\n\nSame Isotope Count\n\n30\n\nSame Parent, Connectivity Count\n\n45\n\nSame Parent, Stereo Count\n\nSame Parent, Isotope Count\n\n38\n\nSame Parent, Exact Count\n\n\n                    Context: \n                    This chunk is part of the Spectral Information section, specifically detailing the Raman spectra data for mitragynine, including technique (FT-Raman), sample source (Cayman Chemical Company), catalog and lot numbers, and copyright information. It immediately precedes the Related Records section, which introduces data on chemical relationships and similar compounds.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_17", "document_index": 37, "latency_s": 30.733773200016003, "prompt_toks": 15219, "completion_toks": 93}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Same Connectivity Count\n\n37\n\nSame Stereo Count\n\nSame Isotope Count\n\n30\n\nSame Parent, Connectivity Count\n\n45\n\nSame Parent, Stereo Count\n\nSame Parent, Isotope Count\n\n38\n\nSame Parent, Exact Count\n\nMixtures, Components, and Neutralized Forms Count\n\n11\n\nSimilar Compounds (2D)\n\nView in PubChem Search\n\nSimilar Conformers (3D)\n\nView in PubChem Search\n\n5.3 Substances\n\n5.3.1 PubChem Reference Collection SID\n\n500802533\n\n5.3.2 Related Substances\n\nAll Count\n\n105\n\nSame Count\n\n88\n\nMixture Count\n\n17\n\n5.3.3 Substances by Category\n\n5.4 Entrez Crosslinks\n\nPubMed Count\n\n19\n\nTaxonomy Count\n\nOMIM Count\n\nGene Count\n\n15\n\n5.5 NCBI LinkOut\n\n6 Chemical Vendors\n\n7 Pharmacology and Biochemistry\n\n7.1 Absorption, Distribution and Excretion\n\n\n                    Context: \n                    This section provides cross-referenced chemical relationships and database identifiers for mitragynine, detailing related compounds by molecular connectivity, stereochemistry, isotope composition, and parent structures. It also lists associated substances, categories, and counts, along with links to PubChem, substance IDs, and external biomedical resources such as PubMed and gene databases, situating mitragynine within broader chemical and biological data networks before transitioning to sections on commercial availability and pharmacological information.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_18", "document_index": 37, "latency_s": 30.67815469999914, "prompt_toks": 15240, "completion_toks": 115}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    5.4 Entrez Crosslinks\n\nPubMed Count\n\n19\n\nTaxonomy Count\n\nOMIM Count\n\nGene Count\n\n15\n\n5.5 NCBI LinkOut\n\n6 Chemical Vendors\n\n7 Pharmacology and Biochemistry\n\n7.1 Absorption, Distribution and Excretion\n\n... LC-MS/MS analysis... was applied to quantify mitragynine in plasma samples of rats (n=8 per sampling time) treated with a single oral dose of 20 mg/kg. The following pharmacokinetic parameters were obtained (mean): maximum plasma concentration: 424 ng/mL; time to reach maximum plasma concentration: 1.26 hr; elimination half-life: 3.85 hr, apparent total clearance: 6.35 L/hr/kg, and apparent volume of distribution: 37.90 L/kg.\n\nPMID:19589735\n\nde Moraes NV et al; J Chromatog B Analyt Technol Biomed Life Sci 877 (24): 2593-7 (2009)\n\n7.2 Metabolism / Metabolites\n\n\n                    Context: \n                    This section transitions from cross-references to external biomedical databases (Entrez Crosslinks, NCBI LinkOut) and a brief mention of chemical vendors, into the detailed Pharmacology and Biochemistry portion of the document. It begins with experimentally determined pharmacokinetic data on mitragynine absorption, distribution, and excretion in animal models, followed by information on its metabolism and metabolites. This situates the chunk at the start of the comprehensive discussion of mitragynine's biological fate and actions after referencing related database links and before deeper pharmacological and biochemical analyses.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_19", "document_index": 37, "latency_s": 31.278396599984262, "prompt_toks": 15253, "completion_toks": 101}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Mitragyna speciosa (Kratom) is ... a drug of abuse. When monitoring its abuse in urine, several alkaloids and their metabolites must be considered. In former studies, mitragynine (MG), its diastereomer speciogynine (SG), and paynantheine and their metabolites could be identified in rat and human urine using /Liquid Chromatography - Tandem Mass Spectometry/ (LC-MS(n)). In Kratom users' urines, besides MG and SG, further isomeric compounds were detected. To elucidate whether the MG and SG diastereomer speciociliatine (SC) and its metabolites represent further compounds, the phase I and II metabolites of SC were identified first in rat urine after the administration of the pure alkaloid. Then, the identified rat metabolites were screened for in the urine of Kratom users using the above-mentioned LC-MS(n) procedure. Considering the mass spectra and retention times, it could be confirmed that SC and its metabolites are so far the unidentified isomers in human urine. In conclusion, SC and\n\n\n                    Context: \n                    This passage appears in the \"Metabolism / Metabolites\" section of the Mitragynine PubChem compound page. It discusses studies on the detection and identification of mitragynine and related alkaloid metabolites (speciogynine, paynantheine, speciociliatine) in urine, emphasizing their relevance as biomarkers for monitoring kratom (Mitragyna speciosa) use and distinguishing among isomeric compounds via advanced LC-MS(n) analytical techniques.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_20", "document_index": 37, "latency_s": 31.11966629998642, "prompt_toks": 15099, "completion_toks": 82}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LC-MS(n) procedure. Considering the mass spectra and retention times, it could be confirmed that SC and its metabolites are so far the unidentified isomers in human urine. In conclusion, SC and its metabolites can be used as further markers for Kratom use, especially by consumption of raw material or products that contain a high amount of fruits of the Malaysian plant M. speciosa.\n\n\n                    Context: \n                    This passage appears in the section discussing the metabolism and detection of mitragynine and related Kratom alkaloids in biological samples. It specifically details the identification of speciociliatine (SC) and its metabolites as additional urinary markers for Kratom use, highlighting their relevance in distinguishing isomeric compounds due to consumption of Mitragyna speciosa (Kratom), particularly from Malaysian plant sources.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_21", "document_index": 37, "latency_s": 28.441269600007217, "prompt_toks": 15259, "completion_toks": 112}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:21249338\n\nPhilipp AA et al; Anal Bioanal Chem 399 (8): 2747-53 (2011)\n\n... The aim of /this/ study is to identify the phase I and II metabolites of mitragynine (MG) in rat and human urine after solid-phase extraction (SPE) using liquid chromatography-linear ion trap mass spectrometry providing detailed structure information in the MSn mode particularly with high resolution. The seven identified phase I metabolites indicated that MG was metabolized by hydrolysis of the methylester in position 16, O-demethylation of the 9-methoxy group and of the 17-methoxy group, followed, via the intermediate aldehydes, by oxidation to carboxylic acids or reduction to alcohols and combinations of some steps. In rats, four metabolites were additionally conjugated to glucuronides and one to sulfate, but in humans, three metabolites to glucuronides and three to sulfates.\n\nPMID:19536806\n\nPhilipp AA et al; J Mass Spectrom 44 (8): 1249-61 (2009)\n\n\n                    Context: \n                    This chunk appears in the \"Pharmacology and Biochemistry\" section under \"Metabolism / Metabolites,\" detailing studies on the metabolic pathways of mitragynine (MG) in rats and humans. Specifically, it describes the identification of phase I and II metabolites of MG in urine, highlighting metabolic transformations such as hydrolysis, O-demethylation, and conjugation with glucuronide or sulfate. This information provides insight into how mitragynine is processed in the body, relevant for toxicological screening and understanding kratom metabolism.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_22", "document_index": 37, "latency_s": 34.764540900010616, "prompt_toks": 15253, "completion_toks": 91}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    During studies on the main Kratom alkaloid mitragynine (MG) in rats and humans, several dehydro analogs could be detected in urine of Kratom users, which were not found in rat urine after administration of pure MG. Questions arose as to whether these compounds are formed from MG only by humans or whether they are metabolites formed from the second abundant Kratom alkaloid paynantheine (PAY), the dehydro analog of MG. Therefore, the aim of /this/ study was to identify the phase I and II metabolites of PAY in rat urine after administration of the pure alkaloid. This was first isolated from Kratom leaves. Liquid chromatography-linear ion trap mass spectrometry provided detailed structure information of the metabolites in the MS(n) mode particularly with high resolution. Besides PAY, the following phase I metabolites could be identified: 9-O-demethyl PAY, 16-carboxy PAY, 9-O-demethyl-16-carboxy PAY, 17-O-demethyl PAY, 17-O-demethyl-16,17-dihydro PAY, 9,17-O-bisdemethyl PAY,\n\n\n                    Context: \n                    This passage is from the \"Metabolism / Metabolites\" section and discusses research on the identification of phase I and II metabolites of the kratom alkaloid paynantheine (PAY) in rats, in relation to dehydro analogs detected in human and rat urine after mitragynine administration. It highlights analytical methods and resulting metabolite profiles to clarify the metabolic pathways and origins of certain kratom-related metabolites found in users.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_23", "document_index": 37, "latency_s": 25.938300899986643, "prompt_toks": 15229, "completion_toks": 115}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PAY, the following phase I metabolites could be identified: 9-O-demethyl PAY, 16-carboxy PAY, 9-O-demethyl-16-carboxy PAY, 17-O-demethyl PAY, 17-O-demethyl-16,17-dihydro PAY, 9,17-O-bisdemethyl PAY, 9,17-O-bisdemethyl-16,17-dihydro PAY, 17-carboxy-16,17-dihydro PAY, and 9-O-demethyl-17-carboxy-16,17-dihydro PAY. These metabolites indicated that PAY was metabolized via the same pathways as MG. Several metabolites were excreted as glucuronides or sulfates. The metabolism studies in rats showed that PAY and its metabolites corresponded to the MG-related dehydro compounds detected in urine of the Kratom users. In conclusion, PAY and its metabolites may be further markers for a Kratom abuse in addition of MG and its metabolites.\n\n\n                    Context: \n                    This chunk is from the section on the metabolism of kratom alkaloids, specifically discussing the identification of phase I metabolites of paynantheine (PAY), a mitragynine analogue, in rat urine. It details that PAY undergoes metabolic pathways similar to mitragynine (MG), with several metabolites excreted as glucuronides or sulfates, and notes the relevance of these metabolites as markers for kratom use and abuse—providing forensic and toxicological insights into kratom alkaloid biotransformation in both rats and humans.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_24", "document_index": 37, "latency_s": 31.96033100000932, "prompt_toks": 15291, "completion_toks": 138}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:19902190\n\nPhilipp AA et al; Anal Bioanal Chem 396 (7): 2379-91 (2010)\n\n7.3 Mechanism of Action\n\n... Mitragynine (MIT), a mu-opioid agonist with antinociceptive and antitussive properties...\n\nPMID:19589735\n\nde Moraes NV et al; J Chromatog B Analyt Technol Biomed Life Sci 877 (24): 2593-7 (2009)\n\nMitragynine, the major alkaloid identified from Kratom, has been reported as a partial opioid agonist producing similar effects to morphine. An interesting minor alkaloid of Kratom, 7-hydroxymitragynine, has been reported to be more potent than morphine. Both Kratom alkaloids are reported to activate supraspinal mu- and delta- opioid receptors, explaining their use by chronic narcotics users to ameliorate opioid withdrawal symptoms.\n\nPMID:18259963\n\nBabu KM et al; Clon Toxicol (Phila) 46 (2): 146-52 (2008)\n\n7.4 Human Metabolite Information\n\n7.4.1 Cellular Locations\n\nMembrane\n\n8 Use and Manufacturing\n\n8.1 Uses\n\n\n                    Context: \n                    This chunk appears in the \"Pharmacology and Biochemistry\" section of the document, specifically detailing the mechanism of action of mitragynine. It summarizes scientific findings that mitragynine, the main alkaloid in Kratom, acts as a partial agonist at mu-opioid receptors with antinociceptive and antitussive effects similar to morphine. It also mentions the more potent alkaloid 7-hydroxymitragynine, and highlights that both compounds activate mu- and delta-opioid receptors, which is relevant to their use in opioid withdrawal management. This precedes sections on metabolite information, cellular localization, and documented uses.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_25", "document_index": 37, "latency_s": 30.75566070000059, "prompt_toks": 15306, "completion_toks": 94}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:18259963\n\nBabu KM et al; Clon Toxicol (Phila) 46 (2): 146-52 (2008)\n\n7.4 Human Metabolite Information\n\n7.4.1 Cellular Locations\n\nMembrane\n\n8 Use and Manufacturing\n\n8.1 Uses\n\nThe Thai medicinal plant Mitragyna speciosa (kratom) is misused as a herbal drug. Besides this, a new herbal blend has appeared on the drugs of abuse market, named Krypton, a mixture of O-demethyltramadol (ODT) and kratom. /Kratom/\n\nPMID:21153588\n\nPhillipp AA et al; Anal Bioanal Chem 400(1): 127-35 (2011)\n\n8.2 Formulations / Preparations\n\nKratom\n\nDEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 114 (July 2005)\n\n8.3 General Manufacturing Information\n\nMitragyna speciosa is a member of the Rubiaceae (coffee) family, and is indigenous to southeast Asia, notably in Thailand and Malaysia. Kratom is the original, common name used in Thailand ... but Mitragyna speciosa has at least half a dozen other common names (e.g., it is known as \"Biak-Biak\" in Malaysia.\n\n\n                    Context: \n                    This chunk transitions from pharmacological and human metabolite information about mitragynine to its uses and manufacturing data. It covers where mitragynine is found (noting its cellular location as membrane-associated), then discusses the misuse of kratom (Mitragyna speciosa) as a herbal drug, its use in new drug mixtures (like Krypton), traditional and modern formulations, and provides background on the plant’s classification, regional origins, and common names.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_26", "document_index": 37, "latency_s": 30.449418799980776, "prompt_toks": 15293, "completion_toks": 100}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DEA; Special Intelligence Brief - Kratom (Mitragyna speciosa). In: Microgram Bulletin (March 2006). Available from, as of March 18, 2011: https://www.justice.gov/dea/programs/forensicsci/microgram/mg0306/mg0306.html\n\nMore than 20 alkaloids have been identified in Kratom by various researchers; the most abundant is mitragynine, an indole alkaloin. /One study/ reported 66.2% mitragynine in the crude base extract of young Kratom leaves from Thailand. ... Several analogues of mitragynine, namely paynantheine, speciogynine, speciociliatine, and 7-alpha-hydroxy-7H-mitragynine, are also found in Kratom extracts. Analysis of a methanol extract with GC/MSD identified both mitragynine and another alkaloid, rhynchophylline.\n\nDEA; Special Intelligence Brief - Kratom (Mitragyna speciosa). In: Microgram Bulletin (March 2006). Available from, as of March 18, 2011: https://www.justice.gov/dea/programs/forensicsci/microgram/mg0306/mg0306.html\n\n\n                    Context: \n                    This excerpt appears in the \"Use and Manufacturing\" section of the document, specifically under general manufacturing information about Kratom (Mitragyna speciosa). It discusses the alkaloid content of Kratom leaves, highlighting mitragynine as the most abundant indole alkaloid, its concentration in leaf extracts, and the identification of several analogues and related alkaloids through chemical analysis techniques. This context supports information on the chemical composition and natural occurrence of mitragynine and related compounds in Kratom.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_27", "document_index": 37, "latency_s": 29.42584449998685, "prompt_toks": 15253, "completion_toks": 88}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ... has been used by natives of Thailand and other regions of Southeast Asia as an herbal drug for decades ... provide energy and relief from muscle strains ... to substitute for opium when opium is not available. It has also been used to manage opiod withdrawal symptoms by chronic opiod users. /Kratom/\n\nDEA; Drugs and Chemicals of Concern. Kratom (Mitragyna speciosa Korth). Dec 2010. US Dept Justice., Drug Enforcement Admin., Off Diversion Control. Available from, as of Jan 7, 2011: https://www.deadiversion.usdoj.gov/drugs_concern/kratom.htm\n\nThere is no legitimate medical use for kratom in the US. /Kratom/\n\nDEA; Drugs and Chemicals of Concern. Kratom (Mitragyna speciosa Korth). Dec 2010. US Dept Justice., Drug Enforcement Admin., Off Diversion Control. Available from, as of Jan 7, 2011: https://www.deadiversion.usdoj.gov/drugs_concern/kratom.htm\n\n9 Identification\n\n9.1 Clinical Laboratory Methods\n\n\n                    Context: \n                    This excerpt appears in the \"Use and Manufacturing\" section of the mitragynine compound entry, summarizing traditional and contemporary uses of kratom (Mitragyna speciosa) in Southeast Asia—as an herbal drug for energy, pain relief, opium substitute, and opioid withdrawal—and noting its lack of recognized medical use in the United States according to DEA sources. It directly precedes the document's section on identification and laboratory analysis methods.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_28", "document_index": 37, "latency_s": 30.03737840001122, "prompt_toks": 15265, "completion_toks": 76}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ... Ultra trace amount of mitragynine in human urine was ... /determined by high performance liquid chromatography coupled to electrospray tandem mass spectrometry/ (HPLC-ESI/MS/MS). Mitragynine was extracted by methyl t-butyl ether (MTBE) and separated on a HILIC column. The ESI/MS/MS was accomplished using a triple quadrupole mass spectrometer in positive ion detection and multiple reactions monitoring (MRM) mode. Ajmalicine, a mitragynine's structure analog was selected as internal standard (IS) for method development. Quality control (QC) performed at three levels 0.1, 1 and 5 ng/mL of mitragynine in urine gave mean recoveries of 90, 109, and 98% with average relative standard deviation of 22, 12 and 16%, respectively. The regression linearity of mitragynine calibration ranged from 0.01 to 5.0 ng/mL was achieved with correlation coefficient greater than 0.995. A detection limit of 0.02 ng/mL and high precision data within-day and between days analysis were obtained.\n\n\n                    Context: \n                    This excerpt appears in the \"Identification\" section of the document and describes an analytical method for the detection and quantification of mitragynine in human urine using HPLC-ESI/MS/MS. It details the sample preparation, instrumentation, internal standard, quality control results, calibration range, and detection limits for forensic or clinical monitoring of mitragynine exposure.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_29", "document_index": 37, "latency_s": 32.157783100003144, "prompt_toks": 15282, "completion_toks": 101}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:19577523\n\nLu S et al; J Chromatog B Analyt Technol Biomed Life Sci 877 (24): 2499-505 (2009)\n\nThe aim of this study was to develop a full-scan gas chromatography-mass spectrometry procedure for monitoring kratom or Krypton intake in urine after enzymatic cleavage of conjugates, solid-phase extraction, and trimethylsilylation. With use of reconstructed mass chromatography ... the presence of mitragynine (MG), 16-carboxy-MG, 9-O-demethyl-MG, and/or 9-O-demethyl-16-carboxy-MG could be indicated, and in case of Krypton, ...the additional presence of O-demethyltramadol (ODT) and its nor metabolite could be indicated. ... Depending on the plant type, dose, administration route, and/or sampling time, further metabolites of MG, paynantheine (PAY), speciogynine (SG), and speciociliatine (SC) could be detected. The limits of detection (signal-to-noise ratio of 3) were 100 ng/mL for the parent alkaloids and 50 ng/mL for ODT...\n\nPMID:21153588\n\n\n                    Context: \n                    This section appears under \"9 Identification\" in the document and describes analytical laboratory methods for detecting mitragynine and its metabolites in human urine. Specifically, it summarizes research on the development and use of gas chromatography-mass spectrometry (GC-MS) and related techniques to monitor intake of kratom (Mitragyna speciosa) and the herbal blend Krypton, including discussions of sample preparation, metabolite identification, and detection limits for various kratom alkaloids and tramadol derivatives.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_30", "document_index": 37, "latency_s": 29.775749699998414, "prompt_toks": 15281, "completion_toks": 94}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:21153588\n\nPhilipp AA et al; Anal Bioanal Chem. 400(1):127-35 (2011)\n\n10 Safety and Hazards\n\n10.1 Hazards Identification\n\n10.1.1 GHS Classification\n\nPictogram(s)\n\nIrritant\n\nSignal\n\nWarning\n\nGHS Hazard Statements\n\nH317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]\n\nH319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]\n\nPrecautionary Statement Codes\n\nP261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P333+P317, P337+P317, P362+P364, and P501\n\n(The corresponding statement to each P-code can be found at the GHS Classification page.)\n\nECHA C&L Notifications Summary\n\nThe GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.\n\n10.1.2 Hazard Classes and Categories\n\nSkin Sens. 1 (100%)\n\nEye Irrit. 2 (100%)\n\n10.2 Accidental Release Measures\n\n10.2.1 Disposal Methods\n\n\n                    Context: \n                    This section appears in the \"Safety and Hazards\" portion of the mitragynine compound entry, detailing its Globally Harmonized System (GHS) hazard classification. It lists relevant hazard pictograms, warnings, specific hazard statements regarding skin and eye irritation, and corresponding precautionary codes. The information is based on regulatory data from the ECHA inventory and is immediately followed by accidental release measures and disposal methods, providing essential safety handling guidance for laboratory and industrial users.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_31", "document_index": 37, "latency_s": 28.948038599977735, "prompt_toks": 15132, "completion_toks": 57}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    10.1.2 Hazard Classes and Categories\n\nSkin Sens. 1 (100%)\n\nEye Irrit. 2 (100%)\n\n10.2 Accidental Release Measures\n\n10.2.1 Disposal Methods\n\nSRP: Criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.\n\n11 Toxicity\n\n11.1 Toxicological Information\n\n11.1.1 Interactions\n\n\n                    Context: \n                    This section appears in the Safety and Hazards portion of the mitragynine compound page, outlining its hazard classifications (Skin Sensitizer and Eye Irritant), recommended disposal methods following accidental release, and then transitions into the detailed Toxicity section, starting with information on toxicological interactions.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_32", "document_index": 37, "latency_s": 30.656650600023568, "prompt_toks": 15282, "completion_toks": 73}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Mitragynine (MG), a major alkaloidal constituent extracted from the plant Mitragyna speciosa Korth, is known to exert an opioid-like activity. ... Previous study showed the involvement of opioid systems in the antinociceptive activity of MG in the tail-pinch and hot-plate tests in mice. In /this/ study, to clarify the opioid receptor subtypes involved in the antinociceptive action of MG, ... the effects of selective antagonists for mu-, delta- and kappa- opioid receptors on antinociception caused by the intracerebroventricular (i.c.v.) injection of MG in the tail-pinch and hot-plate tests in mice /were investigated/. The coadministration of a selective mu-opioid antagonist, cyprodime (1-10 ug, i.c.v.) and the pretreatment with a selective mu1-opioid antagonist naloxonazine (1-3 ug, i.c.v.) significantly antagonized the antinociceptive activities of MG (10 ug, i.c.v.) and morphine (MOR, 3 ug, i.c.v.) in the tail-pinch and hot-plate tests. Naltrindole (1-5 ng, i.c.v.), a selective\n\n\n                    Context: \n                    This excerpt is part of the \"Toxicity\" section, specifically under \"Toxicological Information\" and \"Interactions\", discussing experimental studies on mitragynine’s opioid-like activity, its antinociceptive effects in animal models, and the involvement of mu-, delta-, and kappa-opioid receptors as determined using selective antagonists in mice.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_33", "document_index": 37, "latency_s": 31.44734640000388, "prompt_toks": 15279, "completion_toks": 86}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    significantly antagonized the antinociceptive activities of MG (10 ug, i.c.v.) and morphine (MOR, 3 ug, i.c.v.) in the tail-pinch and hot-plate tests. Naltrindole (1-5 ng, i.c.v.), a selective delta-opioid antagonist, also blocked the effects of MG (10 ug, i.c.v.) without affecting MOR (3 ug, i.c.v.) antinociception. Nor-binaltorphimine, a selective kappa-opioid antagonist, significantly attenuated MG (10 ug, i.c.v.) antinociception in the tail-pinch test but not in the hot-plate test at the dose (1 ug, i.c.v.) that antagonized the antinociceptive effects of the selective kappa-opioid agonist U50,488H in both tests, while it had no effect on MOR antinociception in either tests. These results suggest that antinociception caused by i.c.v. MG is dominantly mediated by mu- and delta-opioid receptor subtypes, and that the selectivity of MG for the supraspinal opioid receptor subtypes differs from that of MOR in mice.\n\n\n                    Context: \n                    This chunk appears in the \"Toxicity\" section under \"Toxicological Information\" and describes experimental findings on how different opioid receptor antagonists affect the antinociceptive (pain-relieving) effects of mitragynine (MG) and morphine in mice, indicating that MG's analgesic effects are mediated primarily by mu- and delta-opioid receptors, with selectivity patterns differing from morphine.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_34", "document_index": 37, "latency_s": 29.68892899999628, "prompt_toks": 15232, "completion_toks": 78}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:9585164\n\nThongpradichote S et al; Life Sci 62 (16): 1371-8 (1998)\n\n11.1.2 Antidote and Emergency Treatment\n\n... A case of kratom dependence /is described/ in a 44-year-old man with a history of alcohol dependence and anxiety disorder. He demonstrated dependence on kratom with withdrawal symptoms consisting of anxiety, restlessness, tremor, sweating and cravings for the substance. A reducing regime of dihydrocodeine and lofexidine proved effective in treating subjective and objective measures of opioid-like withdrawal phenomena, and withdrawal was relatively short and benign. There are only few reports in the literature of supervised detoxification and drug treatment for kratom dependence. ... Observations /in this case/ support the idea that kratom dependence syndrome is due to short-acting opioid receptor agonist activity, and suggest that dihydrocodeine and lofexidine are effective in supporting detoxification. /Kratom/\n\nPMID:20798544\n\n\n                    Context: \n                    This chunk is from the \"11 Toxicity\" section, specifically under \"11.1 Toxicological Information\" and the subsection \"11.1.2 Antidote and Emergency Treatment,\" which provides information on clinical management and treatment approaches for kratom (mitragynine) dependence and withdrawal. It follows detailed discussions of interactions and precedes discussions of human toxicity symptoms and case reports.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_35", "document_index": 37, "latency_s": 30.024524799984647, "prompt_toks": 15229, "completion_toks": 56}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:20798544\n\nMcWhirter L, Morris S; Eur Addict Res 16 (4): 229-31 (2010)\n\n/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/\n\nCurrance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\n\n                    Context: \n                    This chunk appears in the \"Toxicity\" section under \"Antidote and Emergency Treatment,\" providing clinical information on managing mitragynine or kratom toxicity and withdrawal, including a case report of kratom dependence and recommended first aid and emergency procedures for exposure or overdose.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_36", "document_index": 37, "latency_s": 30.20952390000457, "prompt_toks": 15269, "completion_toks": 39}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\n/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/\n\n\n                    Context: \n                    This excerpt appears in the section discussing antidote and emergency treatment under the broader toxicity and safety information for mitragynine, detailing standard first aid and supportive care measures for exposure or poisoning cases.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_37", "document_index": 37, "latency_s": 31.690920399996685, "prompt_toks": 15076, "completion_toks": 54}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160\n\n\n                    Context: \n                    This citation appears in the \"Toxicity\" section of the Mitragynine PubChem compound page, specifically under \"Antidote and Emergency Treatment,\" providing guidance on emergency medical management and first aid procedures for exposure to mitragynine or related hazardous substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_38", "document_index": 37, "latency_s": 29.104756299988367, "prompt_toks": 15222, "completion_toks": 66}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: \"To keep open\", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/\n\n\n                    Context: \n                    This passage provides advanced emergency treatment guidelines for mitragynine (kratom) poisoning, detailing airway management, ventilation, cardiac monitoring, fluid therapy for shock or hypovolemia, seizure control, and eye decontamination; it is part of the document’s toxicity and antidote/emergency treatment section for human exposures.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_39", "document_index": 37, "latency_s": 32.68395880001481, "prompt_toks": 15256, "completion_toks": 114}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160-1\n\n11.1.3 Human Toxicity Excerpts\n\n/SIGNS AND SYMPTOMS/ The primary active alkaloid in kratom is mitragynine; however, other alkaloids are present and account for a variety of effects, which are dose-dependent. Low doses usually produce stimulant effects; higher doses usually produce sedative and euphoric effects. Some users report \"lucid dreaming.\" Individuals who chronically use kratom become thin, their skin darkens (particularly the cheeks), and they experience dry mouth, constipation, and frequent urination. Withdrawal symptoms can include muscle and joint pain, hostility, aggression, eye-watering, and spastic limb movements. /Kratom/\n\nDEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 114 (July 2005)\n\n\n                    Context: \n                    This excerpt is from the \"Toxicity\" section of the mitragynine (kratom alkaloid) PubChem compound page, specifically under \"Human Toxicity Excerpts.\" It summarizes the signs and symptoms of kratom and mitragynine use in humans, including dose-dependent effects (stimulant at low, sedative/euphoric at high), chronic use symptoms, and withdrawal features. This information is provided alongside other clinical, toxicological, and safety data to inform about potential health risks and adverse effects related to mitragynine exposure.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_40", "document_index": 37, "latency_s": 28.771890399977565, "prompt_toks": 15121, "completion_toks": 90}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 114 (July 2005)\n\n/SIGNS AND SYMPTOMS/ Users who combine kratom with nervous system depressants may experience respiratory depression, which may cause them to stop breathing. /Kratom/\n\nDEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 114 (July 2005)\n\n\n                    Context: \n                    This excerpt appears in the \"Toxicity\" section of the mitragynine compound profile, specifically highlighting adverse effects and risks associated with kratom use. It details the signs and symptoms of toxicity, noting that combining kratom with nervous system depressants can lead to dangerous respiratory depression and potentially fatal outcomes. This information is intended to inform on the human health hazards, interactions, and safety concerns related to mitragynine and kratom consumption.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_41", "document_index": 37, "latency_s": 29.58471299998928, "prompt_toks": 15237, "completion_toks": 67}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 114 (July 2005)\n\n/CASE REPORTS/ ... A patient who had abruptly ceased injection hydromorphone abuse self-managed opioid withdrawal and chronic pain using kratom. After co-administering the herb with modafinil he experienced a tonic-clonic seizure, but he reported only modest abstinence once kratom administration stopped. ... The identity of the plant matter he ingested as kratom /was confirmend and no contaminants or adulterants were identified/. ... High-throughput molecular screening and the binding affinity at mu, delta and kappa receptors of mitragynine /were also examined/. ... The predominant alkaloid of kratom, mitragynine, binds mu- and kappa-opioid receptors, but has additional receptor affinities that might augment its effectiveness at mitigating opioid withdrawal...\n\nPMID:18482427\n\nFull text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670991\n\n\n                    Context: \n                    This excerpt appears in the \"Human Toxicity Excerpts\" section under \"Toxicological Information,\" where case reports illustrate adverse effects and pharmacological actions of mitragynine and kratom in humans, including its use for opioid withdrawal, receptor binding profile, and reported toxic events such as seizures during coadministration with other substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_42", "document_index": 37, "latency_s": 30.181237399985548, "prompt_toks": 15245, "completion_toks": 88}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:18482427\n\nFull text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670991\n\nBoyer EW et al; Addiction 103 (6): 1048-50 (2008)\n\n/CASE REPORTS/ A team of Swedish forensic physicians have concluded that nine young people have died over the past year after having taken the legal drug Krypton. ... /Aside from the leaves and extracts from kratom, Krypton has also been found to contain caffeine and the synthetic opioid O-Desmethyltramadol. O-Desmethyltramadol is a breakdown of the product tramadol, which is prescribed in moderation to alleviate severe pain and when taken as Krypton is turned into tramadol in the liver and becomes more potent. It is due to this high potency contained in the O-Desmethyltramadol that the risk of overdosing is considered high, leading to respiratory paralysis./\n\nPMID:21294331\n\nBackstrom BG et al; Lakartidningen 107 (50): 3196-7 (2010) (Article in Swedish) .\n\n\n                    Context: \n                    This excerpt is from the \"Human Toxicity Excerpts\" section of the Mitragynine (kratom) compound information page. It presents case reports describing adverse effects and fatalities linked to the use of kratom and a herbal blend called Krypton, which contains kratom extracts along with caffeine and the synthetic opioid O-desmethyltramadol, highlighting the increased risk of overdose and respiratory paralysis due to potent opioid adulteration.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_43", "document_index": 37, "latency_s": 30.283974599995418, "prompt_toks": 15099, "completion_toks": 87}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:21294331\n\nBackstrom BG et al; Lakartidningen 107 (50): 3196-7 (2010) (Article in Swedish) .\n\nFor more Human Toxicity Excerpts (Complete) data for Mitragynine (8 total), please visit the HSDB record page.\n\n11.1.4 Non-Human Toxicity Excerpts\n\n\n                    Context: \n                    This section appears in the \"Toxicity\" chapter of the document, specifically within the \"Human Toxicity Excerpts\" subsection, which summarizes reported human health effects and case reports associated with mitragynine and kratom use, including clinical signs, symptoms, and adverse events. It is immediately followed by the \"Non-Human Toxicity Excerpts\" subsection, which presents toxicity data from animal and in vitro studies.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_44", "document_index": 37, "latency_s": 30.598001100006513, "prompt_toks": 15286, "completion_toks": 86}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.1.4 Non-Human Toxicity Excerpts\n\n/BEHAVIORAL STUDIES/ Male Spraque Dawley rats (n=40) with the weight ranging from 250-300 grams, were used in this study. ... Dosages of mitragynine (1.0, 5.0, 10.0 and 30.0 mg/kg) were dissolved in 20% Tween and vehicle was given as control injection. Compounds were administered via intraperitoneal injection 30 to 40 minutes prior to the experiment. The rats were initially accustomed to the experimental room for at least 30 minutes prior to the experiment, following 1 hour observation of locomotor activity in the /open-topped/ box. The rats were placed in the center of the grid and for 1 hour the number of squares entered with all four paws was recorded using a video camera mounted on the ceiling. ... Mitragynine as /the/ major alkaloid from Mitragyna speciosa reduced the locomotor activity of the rats treated with 1.0, 5.0, 10.0 and 30.0 mg/kg as compared with saline as control.\n\nMoklas MAM. et al; Advances in Medical and Dental Sciences (2008)\n\n\n                    Context: \n                    This section presents findings from non-human (animal) toxicity studies on mitragynine, specifically behavioral experiments in rats. It summarizes research demonstrating that intraperitoneal administration of various doses of mitragynine leads to reduced locomotor activity in rats, providing insight into the compound's effects and toxicity profile in animal models. This content forms part of the broader toxicity and safety evaluation information for mitragynine within the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_45", "document_index": 37, "latency_s": 30.141177799989237, "prompt_toks": 15269, "completion_toks": 98}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /ALTERNATIVE and IN VITRO TESTS/ ... The effects of pure alkaloid, mitragynine and a methanolic extract of kratom leaves were investigated on neuromuscular junction and compound nerve action potential. ... Wistar rats were killed by cervical dislocation and decapitated. The phrenic nerve-hemidiaphragms, hemidiaphragms and sciatic nerve were isolated. ... Kratom methanolic extract present at 0.1-1 mg/mL and mitragynine (0.0156 mg/mL) decreased the muscle twitch on the isolated phrenic nerve-hemidiaphragm and hemidiaphragm preparation. Muscle relaxation caused by kratom extract (1 mg/mL) was greater than the effect of mitragynine. Pancuronium and succinylcholine potentiated the effect of kratom extract. It also had a direct relaxation effect on the hemidiaphragm muscle. The muscle relaxation caused by kratom extract was not antagonized by neostigmine, tetraethylammonium and calcium chloride. High concentrations of kratom extract (10-40 mg/mL) and mitragynine (2 mg/mL) blocked the nerve\n\n\n                    Context: \n                    This chunk is part of the \"Toxicity\" section, specifically under \"Non-Human Toxicity Excerpts\" and \"ALTERNATIVE and IN VITRO TESTS,\" presenting experimental studies on the neuromuscular and nerve effects of mitragynine and kratom extract in rat tissue preparations. It describes laboratory findings related to muscle twitch inhibition, muscle relaxation, and nerve conduction blockade, contributing to the pharmacological and toxicological characterization of mitragynine.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_46", "document_index": 37, "latency_s": 30.709079099993687, "prompt_toks": 15130, "completion_toks": 97}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    caused by kratom extract was not antagonized by neostigmine, tetraethylammonium and calcium chloride. High concentrations of kratom extract (10-40 mg/mL) and mitragynine (2 mg/mL) blocked the nerve conduction, amplitude and duration of compound nerve action potential. CONCLUSIONS: The mechanism of action of kratom extract might not act as a competitive antagonist of acetylcholine yet its dominant effect was at the neuromuscular junction and not at the skeletal muscle or somatic nerve.\n\n\n                    Context: \n                    This excerpt details findings from in vitro studies on the neuromuscular effects of mitragynine and kratom extract, demonstrating that high concentrations block nerve conduction in isolated rat muscle preparations. It supports the broader section on mitragynine’s toxicity and pharmacology, specifically experimental research describing its mechanism of action on neuromuscular junctions, and distinguishes its effects from those on skeletal muscle and nerves, contributing to understanding of its potential toxicological and pharmacodynamic properties.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_47", "document_index": 37, "latency_s": 29.628330600011395, "prompt_toks": 15053, "completion_toks": 79}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:20371282\n\nChittrakarn S et al; J Ethnopharmacol 129 (3): 344-9 (2010)\n\n\n                    Context: \n                    This citation refers to an in vitro study on the effects of mitragynine and kratom extract on neuromuscular and nerve function in rats, found in the document's Toxicity section under \"Non-Human Toxicity Excerpts.\" The study investigates the muscle relaxant and nerve-blocking properties of mitragynine, relating to its mechanism of action and potential toxicological effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_48", "document_index": 37, "latency_s": 30.418142600014107, "prompt_toks": 15262, "completion_toks": 91}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /ALTERNATIVE and IN VITRO TESTS/ The effect of an indole-alkaloid mitragynine isolated from the Thai medicinal herb kratom (Mitragyna speciosa) on neurogenic contraction of smooth muscle was studied in guinea-pig vas deferens. Mitragynine inhibited the contraction of the vas deferens produced by electrical transmural stimulation. On the other hand, mitragynine failed to affect the responses to norepinephrine and ATP. Mitragynine did not reduce KCl-induced contraction in the presence of tetrodotoxin, prazosin and alpha,beta-methylene ATP. Mitragynine inhibited nicotine- or tyramine-induced contraction. By using the patch-clamp technique, mitragynine was found to block T- and L-type Ca2+ channel currents in N1E-115 neuroblastoma cells. In the Ca2+ measurement by a fluorescent dye method, mitragynine reduced KCl-induced Ca2+ influx in neuroblastoma cells. The ... results suggest that mitragynine inhibits the vas deferens contraction elicited by nerve stimulation, probably through its\n\n\n                    Context: \n                    This excerpt is from the document's section on non-human toxicity and in vitro studies, specifically detailing experimental research on mitragynine's effects at the neuromuscular junction and in smooth muscle tissue. It outlines how mitragynine, the main alkaloid from kratom (Mitragyna speciosa), modulates neurogenic contraction, likely by blocking neuronal calcium channels, providing mechanistic insight into its pharmacological actions outside of opioid receptor interactions.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_49", "document_index": 37, "latency_s": 30.22363779999432, "prompt_toks": 15071, "completion_toks": 113}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    mitragynine reduced KCl-induced Ca2+ influx in neuroblastoma cells. The ... results suggest that mitragynine inhibits the vas deferens contraction elicited by nerve stimulation, probably through its blockade of neuronal Ca2+ channels.\n\n\n                    Context: \n                    This chunk appears within the section summarizing non-human toxicity and in vitro pharmacological studies of mitragynine, specifically describing its mechanism of action at the cellular level. Here, mitragynine is reported to inhibit neurogenic contraction of smooth muscle (e.g., guinea-pig vas deferens) by blocking neuronal calcium (Ca2+) channels, reducing KCl-induced Ca2+ influx in neuroblastoma cells. This provides mechanistic insight into how mitragynine may modulate nerve-stimulated muscle contractions beyond its opioid receptor activity.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_50", "document_index": 37, "latency_s": 30.093173100001877, "prompt_toks": 15048, "completion_toks": 85}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:16107269\n\nMatsumoto K et al; Life Sci 78 (2): 187-94 (2005)\n\n\n                    Context: \n                    This citation refers to an experimental in vitro study describing mitragynine's effects on neurogenic contraction of smooth muscle, discussed in the \"Toxicity\" section of the document. It supports evidence about mitragynine's pharmacological mechanism—specifically, its ability to inhibit vas deferens contraction via blockade of neuronal Ca2+ channels—elaborating on the compound's physiological and neuropharmacological actions.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_51", "document_index": 37, "latency_s": 30.898506099998485, "prompt_toks": 15292, "completion_toks": 96}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /ALTERNATIVE and IN VITRO TESTS/ Effects of mitragynine, an indole alkaloid isolated from Thai medicinal plant kratom (Mitragyna speciosa), on electrically stimulated contraction was studied in the guinea-pig ileum. Mitragynine (1 nM-3 uM) inhibited the ileum contraction elicited by electrical stimulation, and its pD2 value was 6.91 +/- 0.04 (n = 5). Morphine (1 nM-1 uM) also inhibited the electrically stimulated contraction in a concentration-dependent manner (pD2 7.68 +/- 0.11; n = 5). Mitragynine was 10 fold less potent than morphine. Mitragynine (3-10 uM) did not show any effect on the smooth muscle contraction induced by acetylcholine or histamine. Naloxone (10-300 nM) reversed the inhibitory effect of mitragynine on electrically stimulated contraction. Furthermore, naloxone showed a shift of concentration-response curve of mitragynine to the right. There was no significant difference in the affinity of naloxone (i.e. pA2) in the presence of mitragynine or morphine. Mitragynine\n\n\n                    Context: \n                    This excerpt appears in the \"Toxicity\" section of the Mitragynine compound profile, specifically under non-human toxicity and in vitro pharmacology studies. It describes experiments demonstrating that mitragynine inhibits electrically-induced contractions in guinea-pig ileum through opioid receptor mechanisms similar to morphine but with lower potency, and that its effects are reversed by the opioid antagonist naloxone, supporting mitragynine's opioid-like action at the tissue level.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_52", "document_index": 37, "latency_s": 29.517855500016594, "prompt_toks": 15157, "completion_toks": 63}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    a shift of concentration-response curve of mitragynine to the right. There was no significant difference in the affinity of naloxone (i.e. pA2) in the presence of mitragynine or morphine. Mitragynine (3-10 uM) inhibited the naloxone-precipitated withdrawal contraction following a brief (5 min) exposure of the ileum to morphine. Tetrodotoxin (1 uM) and atropine (1 uM) inhibited the withdrawal contraction. The present results suggest that mitragynine inhibits the electrically stimulated contraction of guinea-pig ileum through the opioid receptor.\n\n\n                    Context: \n                    This excerpt is from a section discussing the pharmacological effects and mechanism of action of mitragynine, specifically highlighting in vitro studies on guinea-pig ileum that demonstrate mitragynine's inhibitory effects on electrically stimulated contraction through opioid receptors, comparable to morphine and reversible by naloxone.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_53", "document_index": 37, "latency_s": 30.782991699990816, "prompt_toks": 15154, "completion_toks": 91}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:9061050\n\nWatanabe K et al; Life Sci 60 (12): 933-42 (1997)\n\n11.1.5 Populations at Special Risk\n\nOne potential user population for kratom is opiate addicts who may attempt to self-treat if they do not have access to methadone programs or if they are reluctant to seek professional treatment. /Kratom/\n\nDEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 115 (July 2005)\n\n11.2 Ecological Information\n\n11.2.1 Ecotoxicity Excerpts\n\n\n                    Context: \n                    This section appears in the \"Toxicity\" chapter of the mitragynine (kratom) compound record, following detailed experimental and clinical toxicity data. It highlights \"Populations at Special Risk,\" notably opiate addicts potentially using kratom for self-treatment, with source citations from regulatory briefings. This is immediately followed by the start of the \"Ecological Information\" subsection, introducing data on the compound's environmental and ecotoxicological effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_54", "document_index": 37, "latency_s": 31.663938499987125, "prompt_toks": 15254, "completion_toks": 93}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DEA; Selected Intelligence Brief: Herbal Drug Update: Kratom. In: Microgram Bulletin 38 (7): 115 (July 2005)\n\n11.2 Ecological Information\n\n11.2.1 Ecotoxicity Excerpts\n\n/AQUATIC SPECIES/ The brine shrimp lethality test was used to predict the presence of cytotoxic activity in /Mitragyna speciosa Korth/ extract with some modifications. ... The extracts were tested at 10-100 uL/mL /of artificial sea water/. ... After 24 hours mortality endpoint, the toxicity assessment of three different type of extracts ... was analyzed. The aqueous extract of Mitragyna speciosa Korth showed the lowest toxicity 50 activity against brine shrimp with LC values at 98 uL/mL. The crude alkaloid of the plant exhibited intermediate toxicity activity against brine shrimp larvae with LC values at 62 uL/mL while mitragynine as a major alkaloid exhibited relatively high toxicity to the brine shrimp with LC50 at 44 uL/mL.\n\nMoklas MAM. et al; Advances in Medical and Dental Sciences (2008)\n\n\n                    Context: \n                    This section is part of the document's \"Ecological Information\" chapter, specifically under \"Ecotoxicity Excerpts.\" It reports laboratory data on the toxicity of Mitragyna speciosa (kratom) extracts and its major alkaloid, mitragynine, using a brine shrimp lethality assay, with comparative LC50 values for different extract types. This provides insight into the environmental impact and cytotoxic potential of mitragynine in aquatic species.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_55", "document_index": 37, "latency_s": 29.24801560002379, "prompt_toks": 15294, "completion_toks": 99}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Moklas MAM. et al; Advances in Medical and Dental Sciences (2008)\n\n11.2.2 Natural Pollution Sources\n\nMajor alkaloid of Mitragyna speciosa Korth., Rubiaceae\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1073\n\n11.2.3 Plant Concentrations\n\nPlants containing mitragynine(1).\n\nGenus species\n\nCommon name\n\nConcentration\n\nPlant part\n\nGenus species\n\nMitragyna speciosa KORTH.\n\nCommon name\n\nKratum\n\nConcentration\n\n86 ppm\n\nPlant part\n\nLeaf\n\n(1) USDA; Dr. Duke's Phytochemical and Ethnobotanical Databases. Plants with a chosen chemical. Mitragynine. Washington, DC: US Dept Agric, Agric Res Service. Available from, as of Jan 11, 2011 https://www.ars-grin.gov/duke/\n\n12 Associated Disorders and Diseases\n\n13 Literature\n\n13.1 Consolidated References\n\n13.2 NLM Curated PubMed Citations\n\n13.3 Springer Nature References\n\n13.4 Thieme References\n\n13.5 Wiley References\n\n\n                    Context: \n                    This chunk appears in the \"Ecological Information\" section of the document on mitragynine, specifically following a reference on brine shrimp toxicity. It provides details on the natural sources of mitragynine, noting it as a major alkaloid of Mitragyna speciosa (Kratom), including botanical classification, quantitative plant concentration data, and the plant part (leaf) where mitragynine is found. It precedes the sections on associated disorders, literature, and references.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_56", "document_index": 37, "latency_s": 30.801734499982558, "prompt_toks": 15274, "completion_toks": 89}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12 Associated Disorders and Diseases\n\n13 Literature\n\n13.1 Consolidated References\n\n13.2 NLM Curated PubMed Citations\n\n13.3 Springer Nature References\n\n13.4 Thieme References\n\n13.5 Wiley References\n\n13.6 Chemical Co-Occurrences in Literature\n\n13.7 Chemical-Gene Co-Occurrences in Literature\n\n13.8 Chemical-Disease Co-Occurrences in Literature\n\n14 Patents\n\n14.1 Depositor-Supplied Patent Identifiers\n\nLink to all deposited patent identifiers\n\n14.2 WIPO PATENTSCOPE\n\nPatents are available for this chemical structure:\n\nhttps://patentscope.wipo.int/search/en/result.jsf?inchikey=LELBFTMXCIIKKX-QVRQZEMUSA-N\n\n14.3 Chemical Co-Occurrences in Patents\n\n14.4 Chemical-Disease Co-Occurrences in Patents\n\n14.5 Chemical-Gene Co-Occurrences in Patents\n\n15 Interactions and Pathways\n\n15.1 Chemical-Target Interactions\n\n16 Biological Test Results\n\n16.1 BioAssay Results\n\n17 Taxonomy\n\n18 Classification\n\n18.1 MeSH Tree\n\n18.2 ChEBI Ontology\n\n18.3 ChemIDplus\n\n\n                    Context: \n                    This chunk appears in the later part of the Mitragynine PubChem compound page, following sections on safety, toxicity, ecological data, and identification. It focuses on references, literature, associated disorders and diseases, patents, biochemical interactions and pathways, bioassay results, taxonomy, and various chemical classification systems—serving as a resource for further reading, intellectual property, biological targets, and hierarchical classification information related to mitragynine.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_57", "document_index": 37, "latency_s": 30.65532330001588, "prompt_toks": 15287, "completion_toks": 93}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    15.1 Chemical-Target Interactions\n\n16 Biological Test Results\n\n16.1 BioAssay Results\n\n17 Taxonomy\n\n18 Classification\n\n18.1 MeSH Tree\n\n18.2 ChEBI Ontology\n\n18.3 ChemIDplus\n\n18.4 IUPHAR / BPS Guide to PHARMACOLOGY Target Classification\n\n18.5 ChEMBL Target Tree\n\n18.6 UN GHS Classification\n\n18.7 EPA DSSTox Classification\n\n18.8 LOTUS Tree\n\n18.9 MolGenie Organic Chemistry Ontology\n\n19 Information Sources\n\nCAS Common Chemistry\n\nLICENSE\n\nThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc/4.0/\n\n(-)-Mitragynine\n\nhttps://commonchemistry.cas.org/detail?cas_rn=4098-40-2\n\nChemIDplus\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMitragynine\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0004098402\n\nChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nEPA DSSTox\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears near the end of the document and groups reference sections summarizing biological activity data, taxonomy, chemical classification across multiple authoritative databases (MeSH, ChEBI, ChemIDplus, IUPHAR, ChEMBL, GHS, EPA, LOTUS, MolGenie), and lists major external information sources and licenses relevant to mitragynine. It follows sections on recorded biological test results and directly precedes detailed references and licensing information.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_58", "document_index": 37, "latency_s": 29.60254399999394, "prompt_toks": 15123, "completion_toks": 74}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nEPA DSSTox\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nMitragynine\n\nhttps://comptox.epa.gov/dashboard/DTXSID701032140\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document. It lists authoritative chemical databases and external resources—such as ChemIDplus, EPA DSSTox, and the European Chemicals Agency (ECHA)—that provide regulatory, safety, and chemical information on mitragynine, including relevant licenses and direct links for further data access.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_59", "document_index": 37, "latency_s": 30.47349169998779, "prompt_toks": 15229, "completion_toks": 93}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://comptox.epa.gov/dashboard/DTXSID701032140\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\nUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.\n\nhttps://echa.europa.eu/web/guest/legal-notice\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section of the document, which provides links to external databases and regulatory resources related to mitragynine. Specifically, it lists the EPA CompTox Chemicals Dashboard for mitragynine and introduces the European Chemicals Agency (ECHA) as a source for regulatory and safety information, along with usage conditions for ECHA data. This section serves as a reference hub for users seeking authoritative chemical data and licensing terms.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_60", "document_index": 37, "latency_s": 33.130964800016955, "prompt_toks": 15303, "completion_toks": 70}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://echa.europa.eu/web/guest/legal-notice\n\n(all-S,E)-16,17-Didehydro-9,17-dimethoxy-17,18-seco-20α-yohimban-16-carbonsäuremethylester\n\nhttps://echa.europa.eu/substance-information/-/substanceinfo/100.315.156\n\n(all-S,E)-16,17-Didehydro-9,17-dimethoxy-17,18-seco-20α-yohimban-16-carbonsäuremethylester (EC: 863-118-9)\n\nhttps://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/309996\n\nFDA Global Substance Registration System (GSRS)\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMITRAGYNINE\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/EP479K822J\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing external authoritative databases and regulatory resources (such as ECHA and FDA GSRS) that provide chemical information, legal notices, and identifiers for mitragynine and its synonyms. It supports further reference and verification of chemical data presented throughout the main compound entry.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_61", "document_index": 37, "latency_s": 28.15322410000954, "prompt_toks": 15272, "completion_toks": 54}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMITRAGYNINE\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/EP479K822J\n\nHazardous Substances Data Bank (HSDB)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/web_policies.html\n\nMitragynine\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/hsdb/7901\n\nHuman Metabolome Database (HMDB)\n\nLICENSE\n\nHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.\n\nhttp://www.hmdb.ca/citing\n\nMitragynine\n\nhttp://www.hmdb.ca/metabolites/HMDB0041933\n\nHMDB0041933_msms_2235783\n\nhttps://hmdb.ca/metabolites/HMDB0041933#spectra\n\nChEBI\n\nMitragynine\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section listing external chemical databases and resources for mitragynine, including FDA GSRS, HSDB, HMDB, and ChEBI, along with their license information and direct links to compound records and spectral data.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_62", "document_index": 37, "latency_s": 29.843679299985524, "prompt_toks": 15322, "completion_toks": 71}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    http://www.hmdb.ca/citing\n\nMitragynine\n\nhttp://www.hmdb.ca/metabolites/HMDB0041933\n\nHMDB0041933_msms_2235783\n\nhttps://hmdb.ca/metabolites/HMDB0041933#spectra\n\nChEBI\n\nMitragynine\n\nhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6956\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\nLOTUS - the natural products occurrence database\n\nLICENSE\n\nThe code for LOTUS is released under the GNU General Public License v3.0.\n\nhttps://lotus.nprod.net/\n\nMitragynine\n\nhttps://www.wikidata.org/wiki/Q414299\n\nLOTUS Tree\n\nhttps://lotus.naturalproducts.net/\n\nChEMBL\n\nLICENSE\n\nAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\n\nhttp://www.ebi.ac.uk/Information/termsofuse.html\n\nhttps://www.ebi.ac.uk/chembl/explore/compound/CHEMBL299031\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section at the end of the Mitragynine compound page, listing authoritative external databases and resources—such as HMDB, ChEBI, LOTUS, ChEMBL, and Wikidata—with their respective links and licensing terms for further reference, data, and ontology details related to Mitragynine.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_63", "document_index": 37, "latency_s": 31.649266799999168, "prompt_toks": 15260, "completion_toks": 70}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    http://www.ebi.ac.uk/Information/termsofuse.html\n\nhttps://www.ebi.ac.uk/chembl/explore/compound/CHEMBL299031\n\nChEMBL Protein Target Tree\n\nhttps://www.ebi.ac.uk/chembl/g/#browse/targets\n\nComparative Toxicogenomics Database (CTD)\n\nLICENSE\n\nIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.\n\nhttp://ctdbase.org/about/legal.jsp\n\nmitragynine\n\nhttps://ctdbase.org/detail.go?type=chem&acc=C001801\n\nIUPHAR/BPS Guide to PHARMACOLOGY\n\nLICENSE\n\nThe Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)\n\nhttps://www.guidetopharmacology.org/about.jsp#license\n\nmitragynine\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document, listing external databases and resources related to mitragynine, including ChEMBL, CTD, and IUPHAR, along with their license terms and direct links to mitragynine entries for further chemical, pharmacological, and toxicological information.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_64", "document_index": 37, "latency_s": 30.993855699984124, "prompt_toks": 15242, "completion_toks": 93}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.guidetopharmacology.org/about.jsp#license\n\nmitragynine\n\nhttps://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13149\n\nGuide to Pharmacology Target Classification\n\nhttps://www.guidetopharmacology.org/targets.jsp\n\nCrystallography Open Database (COD)\n\nLICENSE\n\nAll data in the COD and the database itself are dedicated to the public domain and licensed under the CC0 License. Users of the data should acknowledge the original authors of the structural data.\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\nJapan Chemical Substance Dictionary (Nikkaji)\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J8.681I\n\nKEGG\n\nLICENSE\n\nAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license\n\nhttps://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/C09226\n\nNatural Product Activity and Species Source (NPASS)\n\n\n                    Context: \n                    This chunk appears within the \"Information Sources\" section at the end of the document, listing authoritative external databases and resources (such as Guide to Pharmacology, Crystallography Open Database, Nikkaji, KEGG, and NPASS) relevant to mitragynine. It provides links, licensing information, and references for further exploration of chemical, structural, pharmacological, and biological data on mitragynine, supporting comprehensive research and data verification.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_65", "document_index": 37, "latency_s": 28.846075000008568, "prompt_toks": 15363, "completion_toks": 84}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/C09226\n\nNatural Product Activity and Species Source (NPASS)\n\n2-(3-Ethyl-8-Methoxy-1,2,3,4,6,7,12,12B-Octahydro-Indolo[2,3-A]Quinolizin-2-Yl)-3-Methoxy-Acrylic Acid Methyl Ester\n\nhttps://bidd.group/NPASS/compound.php?compoundID=NPC148183\n\nMassBank Europe\n\nLICENSE\n\nhttps://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt\n\nMitragynine\n\nhttps://massbank.eu/MassBank/Result.jsp?inchikey=LELBFTMXCIIKKX-QVRQZEMUSA-N\n\nMassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\nhttps://mona.fiehnlab.ucdavis.edu/documentation/license\n\nMitragynine\n\nhttps://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27LELBFTMXCIIKKX-QVRQZEMUSA-N%27)\n\nSpectraBase\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/4dPrmuj8Hdw\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/14Xo1hui052\n\nMitragynine\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, which lists external databases, resources, and licensing information related to mitragynine. It provides links to chemical and spectral databases, such as KEGG, NPASS, MassBank Europe, MoNA, and SpectraBase, for further details and data on mitragynine's structure, activity, and analytical spectra.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_66", "document_index": 37, "latency_s": 31.133838799985824, "prompt_toks": 15315, "completion_toks": 88}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    SpectraBase\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/4dPrmuj8Hdw\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/14Xo1hui052\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/1FmDJR48MU6\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/2AqcMYPLpSd\n\nMitragynine\n\nhttps://spectrabase.com/spectrum/1FwCJjmhI8\n\nMetabolomics Workbench\n\nMitragynine\n\nhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=49638\n\nSpringer Nature\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/375571263\n\nThieme Chemistry\n\nLICENSE\n\nThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc-nd/4.0/\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/376331415\n\nWikidata\n\nLICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\nmitragynine\n\nhttps://www.wikidata.org/wiki/Q414299\n\nWikipedia\n\nMitragynine\n\nhttps://en.wikipedia.org/wiki/Mitragynine\n\nWiley\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, providing external database links and licensing details for mitragynine, including resource references such as SpectraBase, Metabolomics Workbench, Springer Nature, Thieme Chemistry, Wikidata, Wikipedia, and Wiley. It supports users seeking primary spectral data, compound records, and authoritative chemical information about mitragynine from various scientific databases and publishers.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_67", "document_index": 37, "latency_s": 30.476786500017624, "prompt_toks": 15287, "completion_toks": 67}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\nmitragynine\n\nhttps://www.wikidata.org/wiki/Q414299\n\nWikipedia\n\nMitragynine\n\nhttps://en.wikipedia.org/wiki/Mitragynine\n\nWiley\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/386285977\n\nPubChem\n\nhttps://pubchem.ncbi.nlm.nih.gov\n\nMedical Subject Headings (MeSH)\n\nLICENSE\n\nWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.\n\nhttps://www.nlm.nih.gov/copyright.html\n\nmitragynine\n\nhttps://www.ncbi.nlm.nih.gov/mesh/67001801\n\nMeSH Tree\n\nhttp://www.nlm.nih.gov/mesh/meshhome.html\n\nGHS Classification (UNECE)\n\nGHS Classification\n\nhttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html\n\nMolGenie\n\nLICENSE\n\nCC-BY 4.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMolGenie Organic Chemistry Ontology\n\nhttps://github.com/MolGenie/ontology/\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document, listing external databases and references relevant to mitragynine, including licensing terms and direct links to data entries on platforms such as Wikidata, Wikipedia, Wiley, PubChem, MeSH, UNECE GHS, and MolGenie.\n                "}
{"metadata": {"source": "pubchem", "title": "Mitragynine | C23H30N2O4 | CID 3034396 - PubChem", "description": "Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3034396", "drug": "Mitragynine", "cid": 3034396, "char_count": 50119, "word_count": 6160, "doc_id": "doc_37", "chunk_id": "37::chunk_68", "document_index": 37, "latency_s": 29.6610398000048, "prompt_toks": 15108, "completion_toks": 53}, "content": "Drug: Mitragynine | cid: 3034396\nSource: pubchem | Source description: Mitragynine | C23H30N2O4 | CID 3034396 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MolGenie\n\nLICENSE\n\nCC-BY 4.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMolGenie Organic Chemistry Ontology\n\nhttps://github.com/MolGenie/ontology/\n\nPATENTSCOPE (WIPO)\n\nSID 402799720\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/402799720\n\nNCBI\n\nhttps://www.ncbi.nlm.nih.gov/projects/linkout\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing external databases, licenses, and resources related to mitragynine, including MolGenie, PATENTSCOPE, and NCBI, with links and licensing information.\n                "}
